Hämmig R - Search Results

1

Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.

Hämmig R, Köhler W, Bonorden-Kleij K, Weber B, Lebentrau K, Berthel T, Babic-Hohnjec L, Vollmert C, Höpner D, Gholami N, Verthein U, Haasen C, Reimer J, Ruckes C. Hämmig R, et al. J Subst Abuse Treat. 2014 Oct;47(4):275-81. doi: 10.1016/j.jsat.2014.05.012. Epub 2014 Jun 10. J Subst Abuse Treat. 2014. PMID: 25064422 Clinical Trial.

2

Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method.

Hämmig R, Kemter A, Strasser J, von Bardeleben U, Gugger B, Walter M, Dürsteler KM, Vogel M. Hämmig R, et al. Subst Abuse Rehabil. 2016 Jul 20;7:99-105. doi: 10.2147/SAR.S109919. eCollection 2016. Subst Abuse Rehabil. 2016. PMID: 27499655 Free PMC article.

3

β-Arrestin2 influences the response to methadone in opioid-dependent patients.

Oneda B, Crettol S, Bochud M, Besson J, Croquette-Krokar M, Hämmig R, Monnat M, Preisig M, Eap CB. Oneda B, et al. Among authors: hammig r. Pharmacogenomics J. 2011 Aug;11(4):258-66. doi: 10.1038/tpj.2010.37. Epub 2010 Jun 1. Pharmacogenomics J. 2011. PMID: 20514076

4

Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.

Crettol S, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, Monnat M, Déglon JJ, Preisig M, Eap CB. Crettol S, et al. Among authors: hammig r. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1722-7. doi: 10.1016/j.pnpbp.2008.07.009. Epub 2008 Jul 17. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18687376 Clinical Trial.

5

Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.

Besson J, Beck T, Wiesbeck G, Hämmig R, Kuntz A, Abid S, Stohler R. Besson J, et al. Among authors: hammig r. Swiss Med Wkly. 2014 Mar 31;144:w13933. doi: 10.4414/smw.2014.13933. eCollection 2014. Swiss Med Wkly. 2014. PMID: 24706398 Free article.

6

Agonist Treatment for Opioid Dependence Syndrome: The Impact of Current Understanding upon Recommendations for Policy Initiatives.

Dickson C, Junod V, Stamm R, Jeannot E, Hämmig R, Scholten W, Simon O. Dickson C, et al. Among authors: hammig r. Int J Environ Res Public Health. 2021 Sep 27;18(19):10155. doi: 10.3390/ijerph181910155. Int J Environ Res Public Health. 2021. PMID: 34639456 Free PMC article.

7

Cytochrome P450 2D6 genotype and methadone steady-state concentrations.

Eap CB, Broly F, Mino A, Hämmig R, Déglon JJ, Uehlinger C, Meili D, Chevalley AF, Bertschy G, Zullino D, Kosel M, Preisig M, Baumann P. Eap CB, et al. Among authors: hammig r. J Clin Psychopharmacol. 2001 Apr;21(2):229-34. doi: 10.1097/00004714-200104000-00016. J Clin Psychopharmacol. 2001. PMID: 11270921 Clinical Trial.

8

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.

Crettol S, Déglon JJ, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, Monnat M, Hüttemann H, Baumann P, Eap CB. Crettol S, et al. Among authors: hammig r. Clin Pharmacol Ther. 2005 Dec;78(6):593-604. doi: 10.1016/j.clpt.2005.08.011. Clin Pharmacol Ther. 2005. PMID: 16338275 Clinical Trial.

9

Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel.

Vader JP, Hämmig R, Besson J, Eastus C, Eggenberger C, Burnand B. Vader JP, et al. Among authors: hammig r. Soz Praventivmed. 2003;48 Suppl 1:S1-14. doi: 10.1007/s00038-003-4811-7. Soz Praventivmed. 2003. PMID: 12891872

10

[Psychotropic mushrooms and plants].

Hämmig RB. Hämmig RB. Ther Umsch. 2003 Jun;60(6):317-21. doi: 10.1024/0040-5930.60.6.317. Ther Umsch. 2003. PMID: 12848066 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page